AllianceBernstein’s Cytosorbents Corp CTSO Stock Holding History

AllianceBernstein’s Portfolio CTSO Stock Details CTSO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-54,600	Closed	-$174K	–	3287
2022 Q1	$174K	Buy	54,600 +100	+0.2%	+$358	﹤0.01%	3018
2021 Q4	$228K	Hold	54,500	–	–	﹤0.01%	3029
2021 Q3	$443K	Hold	54,500	–	–	﹤0.01%	2797
2021 Q2	$411K	Buy	54,500 +2,200	+4%	+$18.5K	﹤0.01%	2899
2021 Q1	$454K	Hold	52,300	–	–	﹤0.01%	2697
2020 Q4	$417K	Hold	52,300	–	–	﹤0.01%	2667
2020 Q3	$417K	Hold	52,300	–	–	﹤0.01%	2621
2020 Q2	$518K	Buy	52,300 +8,100	+18%	+$74.4K	﹤0.01%	2585
2020 Q1	$342K	Buy	44,200 +22,200	+101%	+$112K	﹤0.01%	2550
2019 Q4	$85K	Hold	22,000	–	–	﹤0.01%	3054
2019 Q3	$111K	Hold	22,000	–	–	﹤0.01%	3064
2019 Q2	$145K	Buy	22,000 +2,200	+11%	+$15.1K	﹤0.01%	3025
2019 Q1	$150K	Buy	19,800 +8,700	+78%	+$67.7K	﹤0.01%	2960
2018 Q4	$90K	Buy	+11,100	New	+$110K	﹤0.01%	3005

Other funds holding CTSO

Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return

Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AllianceBernstein's CTSO Position: Q2 2022 in Review

AllianceBernstein sold out of Cytosorbents Corp (CTSO) in Q2 2022, closing a stake of 54,600 shares — an estimated $174K sold.

AllianceBernstein first reported a position in CTSO in Q4 2018 and held it in 14 quarters. The position peaked at $518K in Q2 2020. 78 funds tracked by Wall St. Rank hold CTSO as of Q2 2022.

AllianceBernstein reported no remaining Cytosorbents Corp position as of Q2 2022 after selling out during the quarter.
AllianceBernstein sold 54,600 Cytosorbents Corp shares in Q2 2022, an estimated $174K.
AllianceBernstein first reported a position in Cytosorbents Corp in Q4 2018 and held it in 14 quarters.
AllianceBernstein's Cytosorbents Corp position peaked at $518K in Q2 2020.
78 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q2 2022.

Based on AllianceBernstein's 13F filing for Q2 2022, filed 15 Aug 2022.